Eighty-nine consecutive patients attending for day-case colonoscopy were randomly allocated either polyethylene glycol/balanced electrolyte (PEG) mixture (n = 45) or a mannitol/Picolax mixture (n = 44). Both preparations were administered in two fractions. Patients recorded their experience of the preparation on a questionnaire and one of two experienced endoscopists (unaware of the type of preparation given) assessed the result of bowel cleansing. Carbon dioxide insufflation was used for all examinations.
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Good/excellent bowel cleansing occurred in significantly more patients given PEG, 43 (96%), than those allocated mannitol/Picolax, 34 (77%), p = 0.01.
More patients receiving mannitol/Picolax were able to complete the preparation in full than patients receiving PEG (38 vs 27, p = 0.01). More patients found the taste of mannitol/Picolax pleasant compared to PEG (46% vs 20%). Both preparations had a similar side-effect profile. Of those patients tested, 13% receiving mannitol/ Picolax had a postural drop in blood pressure and blood parameters suggestive of mild dehydration.
A fractionated administration of PEG as a bowel preparation for day-case colonoscopy is well tolerated and superior as a cleansing agent to a mannitol/Picolax combination. It has been our experience over several years that a mixture of magnesium citrate with mannitol (mannitol/Picolax) produces a sweet, lowvolume (2 x 500 ml fractions) lemon-tasting solution that is both well tolerated and effective in cleansing the bowel. No study has previously investigated the possible benefits of mannitol/ Picolax mixture. We therefore decided to assess the efficacy, acceptability and safety of mannitol/Picolax by comparing it to PEG as a bowel preparation for day-case colonoscopy. 22.74 g, sodium chloride 5.86 g, potassium chloride 2.97 g, aspartamine 0.2 g; Kleanprep, Norgine Ltd, Oxford, UK) or one litre of mannitol/Picolax mixture (mannitol 100 mg, sodium picosulphate 10 mg, magnesium oxide 3 g, citric acid 12 g). All patients were allowed a normal diet until the afternoon before the day of colonoscopy and thereafter clear fluids only. Patients receiving PEG were given the option of chilling the solution which was then drunk according to the following protocol. Those patients with a morning appointment (n = 4) 18 .00 h the day before colonoscopy followed by a further 1 1 at 06.00 h the following morning. Patients with an afternoon appointment for colonoscopy (n = 41) were asked to drink 2 1 the evening before and 2 1 on the morning of the procedure. In the mannitol/Picolax group, patients were instructed to drink 500 ml of the chilled solution at 18.00 h the day before and a further 500 ml at 06.00 h on the morning of colonoscopy. They were also asked to drink at least 1 1 of water in addition to their preparation.
Materials and methods

Eighty
On arrival at the Endoscopy Unit all patients were given a questionnaire asking about their experience of the preparation, including taste, ability to complete the preparation, side-effects encountered and whether or not they would be prepared to repeat the preparation if a future colonoscopy were necessary (table 1). In the first 42 patients, lying and standing blood pressures were recorded and a venous blood sample taken for haemoglobin, packed cell volume, urea and electrolytes and serum osmolarity.
One of two experienced colonoscopists (CBW, BPS), who were unaware of the type of preparation given, performed the examinations and scored the degree of bowel cleansing according to the descriptions in table 2. Carbon dioxide was used as the insufflating agent during all examinations.
In the PEG group there were 28 females, and 17 males, age range 27-87 years, median 52 years. In the mannitol/Picolax group there were 22 females and 22 males age range 18-73 years, median 49 years.
STATISTICAL ANALYSIS
The preparation was allocated to patients according to a randomised block design (block size six) to aid concealment and ensure near uniform allocation to the two treatment groups. Data for cleansing of the colon, taste, ability to complete the preparation and patient sideeffects were assessed using Fisher's exact test after combining the data into 2 by 2 contingency tables. Because of multiple testing, significance demanded a calculated p-value of less than 0.01.
Results
Forty-five patients were randomised to receive PEG and 44 mannitol/Picolax. The two patient groups were similar with regard to age, sex, indication for colonoscopy, findings at colonoscopy, history of constipation, laxative administration, and drug history. Thirty-eight patients (86%) receiving mannitol/Picolax were able to complete their preparation in full as opposed to 27 (60%,) given PEG (p = 0.01). More patients found the taste of mannitol/ Picolax 'pleasant' compared to PEG (460o vs 20%o,p=O0.01).
There were no significant differences between the two preparations in the incidence of nausea, vomiting, fullness, dizziness, abdominal cramps or peri-anal soreness. When asked if they would be prepared to repeat the preparation 39 patients (860o) in the PEG group said they would compared to 41 (930O) in the mannitol/Picolax group (non-significant).
Good or excellent bowel cleansing occurred in significantly more patients receiving PEG (96%) than those allocated mannitol/Picolax (77%), p = 0.01. Rescheduling of the procedure and additional cleansing was necessary in one patient in the PEG group but five receiving mannitol/Picolax.
Of the 42 patients who underwent assessment of blood pressure and blood parameters, 20 received PEG and 22 mannitol/Picolax. There was a postural drop in blood pressure (systolic drop of 20 mmHg on standing), raised packed cell volume and raised serum osmolarity in three patients receiving mannitol/Picolax preparation. One patient receiving PEG had a postural drop in blood pressure but this was not accompanied by any biochemical or haematological abnormalities.
Discussion
An 'ideal' bowel preparation for colonoscopy would be easy to administer, have a rapid onset of action, produce satisfactory cleansing in approaching 100% of all patients, be cheap, easily packaged and above all be safe and acceptable to the patient. Prior to this study it was our impression that mannitol/Picolax mixture might come close to this ideal. Certainly it is cheap (approximate cost per patient = &0.60p) and easily packaged. This study has also shown mannitol/Picolax mixture to be acceptable to the patient. 910% recorded its taste as pleasant or tolerable and 86% were able to complete it in full; probably a consequence of the relatively small volume and split-administration. However, mannitol/Picolax is clearly inferior as a cleansing agent to two-dose PEG even though the 770o good/excellent cleansing rate compares favourably with preparation by two sachets of Picolax alone. 9 Recently mannitol has been disregarded as a bowel preparation because of reports that its use may be associated with a build-up of potentially explosive gases." However the risk of combustion is only present if oxygen is used as the insufflating agent.'2 We routinely use carbon dioxide insufflation to reduce postprocedure bloating which therefore allows mannitol to be used safely. Of more concern than a risk of combustion was the finding of clinical and biochemical dehydration in three patients receiving mannitol/Picolax. All were over 60 years old and we would therfore advise caution in prescribing mannitol/Picolax to elderly patients and those with known cardiac or renal problems.
We were surprised to find that such a high percentage (960o) of patients receiving PEG had excellent or good cleansing as rated by the endoscopist. This was despite the fact that the Properties of the ideal bowel preparation * high patient acceptability * easy administration * rapid onset of action * effective in all types of patient * cheap * easily packaged * safe Learning/summary points * PEG is superior to mannitol/Picolax mixture as bowel preparation for day-case colonoscopy * a fractionated administration of PEG may improve patient tolerability * mannitol/Picolax is an acceptable bowel preparation in fit, young patients, intolerant of PEG, provided carbon dioxide is available for insufflation administration had been split into two doses and that 36% of patients did not complete their preparation in full. PEG was also well tolerated by the majority of our patients, possibly a reflection of the split-administration regime. Rosch et al have demonstrated that a fractionated administration of the PEG mixture is preferred by in-patients asked to drink up to 6 1 of solution.'3 Using our 4 1 split-administration regime in out-patients, we have recorded only a 6% incidence of vomiting. This compares favourably with studies in which the full 4 1 is drunk continuously (the currently recommended method of administration), where a 10-20% incidence of vomiting has been recorded.8'9"4 Of the 20 patients who both received PEG and were tested for postural changes in blood pressure and changes in blood parameters, only one patient showed an abnormality: a postural drop in blood pressure in a 56-year-old man who was also taking antihypertensive medication. This low incidence of biochemical or haemodynamic abnormality further emphasises the beneficial safety profile of the PEG mixture. '5 In conclusion two-dose PEG oral lavage is superior as a cleansing agent to a mannitol! Picolax mixture. The high patient acceptability of PEG seen in this study is likely to be related to the split administration regime and we would recommend this method of administration when using PEG. For younger patients intolerant of PEG, mannitol/Picolax is an acceptable alternative as bowel preparation for colonoscopy, provided carbon dioxide is used as the insufflating agent during the procedure.
